STOCK TITAN

eFFECTOR Therapeutics Inc SEC Filings

LWACU NASDAQ

Welcome to our dedicated page for eFFECTOR Therapeutics SEC filings (Ticker: LWACU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

LightWave Acquisition Corp. filings document a Cayman Islands blank-check company and emerging growth company with a SPAC capital structure. The record covers IPO-related material events, units composed of Class A ordinary shares and redeemable warrants, warrant exercise terms, ordinary-share disclosures, and governance matters tied to the issuer's public-company status.

Regulatory filings also include current reports on material definitive agreements and other events, exchange-listed Class A shares and warrants, and Form 12b-25 late-report notifications for periodic reporting. These documents describe LWACU's reporting obligations, capital structure and SPAC-related disclosure framework.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

How many eFFECTOR Therapeutics (LWACU) SEC filings are available on StockTitan?

StockTitan tracks 19 SEC filings for eFFECTOR Therapeutics (LWACU), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for eFFECTOR Therapeutics (LWACU)?

The most recent SEC filing for eFFECTOR Therapeutics (LWACU) was filed on July 9, 2025.